CVRx (NASDAQ:CVRX – Get Free Report) had its price objective increased by stock analysts at Craig Hallum from $20.00 to $22.00 in a report released on Friday,Benzinga reports. The brokerage currently ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Craig-Hallum raised the firm’s price target on CVRx (CVRX) to $22 from $20 and keeps a Buy rating on the shares. CVRx posted a modest beat in ...

CVRx (CVRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fintel reports that on January 14, 2025, William Blair upgraded their outlook for CVRx (NasdaqGS:CVRX) from Market Perform to ...

William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...

William Blair analyst Margaret Kaczor upgraded CVRx (CVRX) to Outperform from Market Perform.Stay Ahead of the Market:Discover outperforming ...

CVRx anticipates a 35% increase in Q4 2024 revenue and a 30% increase in FY24 revenue, with shares down 1.55% premarket.

Fourth quarter revenue expected to be $15.2 million to $15.3 million, representing growth of 35%Full year revenue expected to ...

Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies ...

Buy CVRX near 13.23 target n/a stop loss @ 13.19. Details The technical summary data tells us to buy CVRX near 13.23, but there is no current upside target from the summary table. In this case we ...